Psychedelic Healing

• Examines the therapeutic potential of expanded states, underground psychedelic psychotherapy, harm reduction, new approaches for healing individual and collective trauma, and training considerations • Addresses challenging psychedelic experiences, spiritual emergencies, and the central importance of the therapeutic relationship • Details the use of cannabis as a psychedelic tool, spiritual exploration with LSD, micro-dosing with Iboga, and MDMA-assisted psychotherapy for PTSD Exploring the latest developments in the flourishing field of modern psychedelic psycho-therapy, this book shares practical experiences and insights from both elders and newer research voices in the psychedelic research and clinical communities. The contributors examine new findings on safe and skillful work with psychedelic and expanded states for therapeutic, personal, and spiritual growth. They explain the dual process of opening and healing. They explore new approaches for individual inner work as well as for the healing of ancestral and collective trauma. They examine the power of expanded states for reparative attachment work and offer insights on the integration process through the lens of Holotropic Breathwork. The contributors also examine the use of cannabis as a psychedelic tool, spiritual exploration with LSD, microdosing with Iboga, treating depression with psilocybin, and MDMA-assisted psychotherapy for PTSD. Revealing diverse ways of working with psychedelics in terms of set, setting, and type of substance, the book concludes with discussions of ethics and professional development for those working in the field as well as explores considerations for training the next generation of psychedelic therapists.

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.

This is a book about the intersections of three dimensions. The first is the way social scientists and historians treat the history of psychiatry and healing, especially as it intersects with psychedelics. The second encompasses a reflection on the substances themselves and their effects on bodies. The third addresses traditional healing, as it circles back to our understanding of drugs and psychiatry. The chapters explore how these dimensions are distinct, but deeply intertwined, themes that offer important insights into contemporary healing practices. The intended audience of the volume is large and diverse: neuroscientists, biologists, medical doctors, psychiatrists, psychologists; mental health professionals interested in the therapeutic application of psychedelic substances, or who work with substance abuse, depression, anxiety, and PTSD; patients and practitioners of complementary and alternative medicine; ethnobotanists and ethnopharmacologists; lawyers, criminologists, and other specialists in international law working on matters related to drug policy and human rights, as well as scholars of religious studies, anthropologists, sociologists, and historians; social scientists concerned both with the history of science, medicine, and technology, and concepts of health, illness, and healing. It has a potentially large international audience, especially considering the increasing interest in “psychedelic science” and the growing spread of the use of traditional psychoactives in the West.

This short book is packed with fascinating information about one of the most controversial areas of psychiatry - psychedelic therapy. Research within this field of medicine has recently been resumed, having been banned for nearly half a century, and results of completed studies on the effects of psychedelics on war veterans with intractable PTSD and on subjects with treatment-resistant depression, have been very promising. Currently, controlled studies on the efficacy of psychedelic treatment for depression are taking place at Johns Hopkins University School of Medicine in the USA and at the Neuropsychopharmacology Unit in the Division of Brain Sciences, at Imperial College London. The results so far suggest that within a decade, psychedelics could become a legal pharmacological treatment for depression and PTSD. In addition, these substances are known for their ability to dramatically enhance creativity and to provide profound spiritual insights, but perhaps the most fascinating part of this book is the second section which describes the experiences of numerous famous individuals who owe much of their significant success in life to these life-changing chemicals, the list includes: Apple pioneer, Steve Jobs who credits his outside-the-box perspective to LSD, which bestowed upon him an entirely different vision of existence that inspired a lot of Apple's product inventions and success; Francis Crick, the father of modern genetics who perceived the double helix shape of DNA during an LSD trip. The award-winning cosmologist Carl Sagan who stated: "e;the Hindu mystical experience"e; of union with the universe "e; is pre-wired into us, requiring only 200 micrograms of LSD to be made manifest."e; Oliver Wolf Sacks, author and Professor of neurology and psychiatry at Columbia University: "e;I'm glad I had the experience. It taught me what the mind is capable of."e; Susan Blackmore, English freelance writer, lecturer, author of The Meme Machine who stated: "e;The ultimate psychedelic, whose discoverer is fit and well at a hundred years old, is LSD...Not only can it induce mystical experiences, but can treat neurosis and alleviate pain and fear in the terminally ill. We may be wasting a potential "e;wonder drug."e; Tom Robbins, American author named one of the 100 Best Writers of the 20th Century by Writer's Digest magazine: "e;Frankly, the day I ingested 300 micrograms of pure Sandoz LSD was the most rewarding day of my life, the one day that I would not trade for any other... psychedelics can enhance the life of any intelligent, courageous person, and they might even represent our last great hope for planetary survival."e; And this list also includes numerous other celebrity figures such as: Aldous Huxley; Chemistry Nobel Prize winner, Kary Banks Mullis; VRML inventor Mark Pesce; New York Times best-selling author and doctor, Andrew Weil; Bill Wilson, founder of Alcoholics Anonymous; Rupert Sheldrake; Colin Wilson; Walter Houston Clark; Stephen John Fry; Robert Greene; Robin Skynner; Abraham Maslow; Robert Anton Wilson; Huston Smith; Alan Watts; Ken Kesey; Cary Grant; and Time Magazine publisher Henry Luce, who in the 1950's, subsequently wrote and published in Time Magazine, some very positive articles about the drug's potential, in which he praised Sandoz and LSD itself as providing: "e;an invaluable weapon to psychiatrists."e;

Psychedelic Psychotherapy contains valuable insiders' information for those using psychedelics for their own healing, and for practitioners who facilitate their sessions. Its focus is the nitty-gritty of healing trauma using MDMA, LSD, and psilocybin.

The invitation to write a foreword for this book came at an opportune time in the development of the field of psychedelic-assisted therapy, amid the emergence of the future iteration of mental health services, delivered by the promises of the psychedelic renaissance. Also alive in this context are the substantial individual, social and cultural repercussions of a global pandemic on mental health and human behavior. A growing body of research shows encouraging clinical results in treating trauma, depression, demoralization, end-of-life existential issues, addiction, and eating disorders using MDMA, psilocybin, ketamine, and other psychedelic medications. However, the field of psychedelic-assisted therapy has gained accelerated support from donors, the medical establishment, and corporate investors in recent years. Along with the enthusiasm, recognition, funding, and media coverage directed toward psychedelic-assisted therapy, ethical standards; the lack of adequate training; and issues of accessibility, sustainability, diversity and inclusion are increasingly becoming part of the movement's forefront. These gaps in the emerging field highlight the need for more guidance and structure around ethical, clinical, and social considerations for these innovative treatments. This book can serve as a cornerstone for the field of psychedelic-assisted therapy at this time. This essential contribution offers a depth-oriented, somatic and relational therapeutic approach, emphasizing the imperative of ethical standards, the relevance of the therapeutic use of touch, the significance of the unconscious in the construction of symbolic meaning and intersubjective processes, and the need for trauma -informed approaches while centering liberation psychology and decolonial practices. The topics covered in this book and the themes embraced by the authors are of great relevance and are not yet comprehensively articulated in existing publications on psychedelic-assisted therapy. The diverse authors of this book approach their chapters based on their diverse social and cultural identities, as well as their extensive clinical experience providing psychedelic-assisted therapy in government-approved clinical research, private practice, and nonprofit organization settings. Their contributions aim at a vision of psychedelic-assisted therapy centered on decolonial practices, attuned to the somatic, imaginal, cultural and relational dimensions of being, allowing the emergence of transpersonal processes. Each chapter elaborates practical and theoretical aspects of this treatment modality through a unique theoretical framework, providing inspiration and guidance to readers working in this field as well as those compelled to psychedelic work for personal transformation.

Integral Psychedelic Therapy is a groundbreaking, evidence-based collection that explores how psychedelic medicine can be incorporated into contemporary psychotherapy. This book builds on current psychedelic research by providing an in-depth articulation of the practice of psychedelic therapy, weaving together a variety of complementary therapeutic frameworks, case examples, and practical guidance for cultivating a highly effective, ethically grounded, integral approach. Chapters by a diverse set of practicing psychotherapists and leading researchers aim to provide practitioners with a method that centers liberation of all dimensions of being through intersectional, client-centered, trauma-informed, and attachment-focused practices, alongside thoughtful attunement to the relational, somatic, imaginal, cultural, and transpersonal dimensions of healing. Integral Psychedelic Therapy will be essential reading for psychotherapists in practice and in training as well as those seeking personal healing and holistic transformation.